Shanghai Labway Clinical Laboratory Co

Shanghai Labway Clinical Laboratory Co OCF Margin

The Operating Cash Flow Margin of Shanghai Labway Clinical Laboratory Co (301060.SZ) as of Nov 2, 2026 is 18.57 %. In the previous year, Operating Cash Flow Margin was 12.42 % — a change of 49.54% (higher).

OCF Margin

18.57 %

YoY

49.54%

Last updated:

Operating Cash Flow Margin of Shanghai Labway Clinical Laboratory Co is 2025 18.57 % . Operating Cash Flow Margin of Shanghai Labway Clinical Laboratory Co was 2024 12.42 % . It decreases by 49.54% higher compared to the previous year.

The Shanghai Labway Clinical Laboratory Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
17.55 CNY
Jan 1, 2019
6.12 CNY
Jan 1, 2020
13.56 CNY
Jan 1, 2021
12.57 CNY
Jan 1, 2022
2.00 CNY
Jan 1, 2023
32.67 CNY
Jan 1, 2024
12.42 CNY
Jan 1, 2025
18.57 CNY
The Shanghai Labway Clinical Laboratory Co OCF Margin history
YEAROCF MarginYoY
18.57 %+49.54%
12.42 %-61.99%
32.67 %+1,529.91%
2.00 %-84.05%
12.57 %-7.30%
13.56 %+121.51%
6.12 %-65.13%
17.55 %-269.67%
-10.35 %-406.79%
3.37 %-74.25%
13.10 %-185.62%
-15.30 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Labway Clinical Laboratory Co Stock analysis

What does Shanghai Labway Clinical Laboratory Co do? Shanghai Labway Clinical Laboratory Co., Ltd. generates revenue through medical and pathological examination services, including pathological diagnosis, molecular examination, biochemical examination, immune examination, microbial examination, clinical basic examination, and physical and chemical examination. The company also sells in vitro diagnostic instruments, reagents, and related accessories and consumables. Its primary customers are healthcare providers and medical institutions requiring diagnostic services and diagnostic products. The business segments are medical testing services and in vitro diagnostic product sales. The company's medical testing services cater to hospitals and clinics seeking comprehensive diagnostic solutions, while the in vitro diagnostic product sales target healthcare facilities needing equipment and supplies for laboratory operations. These services and products are provided to clients across China, focusing on the healthcare sector's demand for accurate and timely diagnostic capabilities. Shanghai Labway's revenue streams are derived from both service fees for examinations and sales of diagnostic instruments and reagents. The company's offerings align with the growing need for advanced medical diagnostics in China's expanding healthcare market, serving a broad client base within the medical industry. Shanghai Labway Clinical Laboratory Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Labway Clinical Laboratory Co stock

Operating Cash Flow Margin of Shanghai Labway Clinical Laboratory Co is 18.57 % in 2025.

Operating Cash Flow Margin of Shanghai Labway Clinical Laboratory Co changed from 12.42 % to 18.57 %, representing a 49.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Shanghai Labway Clinical Laboratory Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Shanghai Labway Clinical Laboratory Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Shanghai Labway Clinical Laboratory Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Shanghai Labway Clinical Laboratory Co